Certified by Founder Lodge
Hatteras Venture Partners
United States - Durham, NC
INVESTOR
1 Disclosed Funding Rounds $15,100,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Hatteras Venture Partners is a venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportu
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 09 ,2022 | Series A | $15,100,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
 Cardiosense |
December, 09 ,2022 | Series A | $15,100,000 |
 Mercy BioAnalytics, Inc. |
April, 04 ,2023 | Series A | $41,000,000 |
 Aer Therapeutics, Inc. |
April, 17 ,2023 | Series A | $36,000,000 |
 Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
 Ten63 Therapeutics |
June, 16 ,2023 | Series A | $5,190,000 |
 Elligo Health Research |
October, 03 ,2023 | Unknown | $40,000,000 |
 iVEAcare, Inc. |
April, 23 ,2024 | Series A | $27,500,000 |
 AtaCor Medical, Inc. |
April, 25 ,2024 | Series C | $28,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
